Press Releases from http://www.transparencymarketresearch.com/alpha-1-antitrypsin-deficiency-treatment-market.html (1 total)
Alpha 1-antitrypsin deficiency treatment market is a highly promising and attrac …
Alpha 1-Antitrypsin Deficiency Treatment Market: Overview
Alpha 1-antitrypsin deficiency is an inherited genetic disorder that causes insufficient production of the protein alpha 1-antitrypsin (A1AT) in individuals. A1AT is a protease inhibitor that has the capability to protect body tissues from enzymes of various inflammatory cells such as neurophil elastase. Insufficient production of this protein leads to pulmonary medical complications chronic obstructive pulmonary disease (COPD), cirrhosis and emphysema. At present, the alpha…
